- •Anemia
- •Syndromes in anemia
- •Definition of anemia
- •Risk factors for anemia
- •Classification of anemia
- •Classification of anemia
- •Classification by severity
- •Symptoms and signs of anemia
- •Initial investigations in anemia
- •Iron deficiency anemia
- •Causes of iron-deficiency anemia
- •Syndromes in IDA
- •Symptoms of iron deficiency
- •Clinical presentation of IDA
- •Diagnostics of IDA
- •Poikilocytosis
- •Iron metabolism parameters and CBC changes in iron deficiency
- •Bone marrow in iron deficiency
- •Additional tests for differential diagnostics in IDA
- •Management of IDA
- •Megaloblastic anemia
- •Daily need in B12 and folic acid
- •Vitamin B12 absorption and transport.
- •Classification Of The Megaloblastic Anemias
- •Classification Of The Megaloblastic Anemias
- •B12 deficiency: pathogenesis of symptoms
- •Clinical presentation of megaloblastic anemia
- •Funicular myelosis
- •Diagnostics
- •Peripheral blood smear in megaloblastic anemia
- •Treatment
- •Response to therapy with B12 – reticulocytosis within 7-10 days
- •Hemolytic anemia
- •Pathogenesis of hemolytic anemia
- •Classification of hemolytic anemia
- •Mechanisms of different types of hemolysis
- •Classification Of Disorders Due To Hemoglobin Abnormalities
- •Hemolysis Due To Antibodies
- •Drugs Causing Hemolysis In Subjects
- •Clinical presentation
- •Diagnostics
- •Principles of treatment
- •Aplastic anemia
- •Clinical presentation of aplastic anemia
- •Pancytopenia
- •Aplastic anemia treatment
B12 deficiency: pathogenesis of symptoms
|
B12 deficiency |
|
|
Co-enzyme |
|
Co-enzyme methylcobalamine |
deoxyadenosincobalamine |
|
|
||
|
Impaired fatty acids |
|
Impaired thymidine synthesis |
metabolism |
|
Impaired DNA synthesis |
Accumulation of toxic |
|
methylmalonic and propionic acids |
||
|
Changes in hemopoiesis |
Changes in epithelial |
Nervous system involvement |
|
(megaloblastic anemia, |
tissues (atrophy of GIT |
||
(funicular myelosis, impaired |
|||
leykopenia, |
mucosa) |
||
peripheral sensitivity) |
|||
thrombocytopenia) |
|
||
|
|
Clinical presentation of megaloblastic anemia
•Severe anemia
–Circulatory-hypoxic syndrome
–Anemic syndrome
•Hunter`s Glossitis: smooth tongue due to loss of papillae
•Funicular myelosis:
–Subacute combined degeneration of the cord in cobalamine deficiency. Abnormal gait,
–loss of balance,
–speech impairment
–loss of proprioceptive and vibratory senses
•Lemon-yellow skin
•Hyperpigmentation of the skin and abnormal pigmentation of hair due to increased melanin synthesis
•Mental changes, from irritability to psychosis
•Splenomegaly
Funicular myelosis
Diagnostics
•Hyperchromia, macrocytosis
•Megaloblastosis
•Single and multiple Howell-Jolly bodies (nuclear fragments in RBC)
•Cabot rings (remnants of mitotic spindles)
•Hypersegmented neutrophils
•Pancytopenia
•Hyperbilirubinemia (↑indirect bb due to hemolysis in the bone marrow)
•High LDH activity
•Low reticulocytes
•Low B12 and/or folates
•Bone marrow is hypercellular (”blue”) with erythroid hyperplasia – megaloblastic erythropoiesis
Peripheral blood smear in megaloblastic anemia
Treatment
•Life-long treatment with cobalamine (parenteral)
•Oral supplements of folic acid
•If B12-deficiency is not excluded treat with both supplements
Response to therapy with B12 – reticulocytosis within 7-10 days
Hemolytic anemia
•Hemolysis – premature destruction of erythrocytes.
•A hemolytic anemia will develop if bone marrow activity cannot compensate for the erythrocyte loss.
Pathogenesis of hemolytic anemia
Повреждающий фактор
Increased permeability of erythrocytic membranes Accumulation of active osmotic substances (Na+, K+, Ca2+ etc.)
Hyperosmia of cytozol
Hyperhydration and swelling of erythrocytes
Destruction of plasmolemma - hemolysis
normal |
Damaging factor |
hemolysis |